# reload+after+2024-01-22 19:26:57.193065
address1§Radnor Corporate Center
address2§Building One Suite 200 100 Matsonford Road
city§Radnor
state§PA
zip§19087
country§United States
phone§610 386 1700
website§https://www.avantorsciences.com
industry§Specialty Chemicals
industryKey§specialty-chemicals
industryDisp§Specialty Chemicals
sector§Basic Materials
sectorKey§basic-materials
sectorDisp§Basic Materials
longBusinessSummary§Avantor, Inc. engages in the provision of mission-critical products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides logistics, chemical and equipment tracking, and glassware autoclaving, as well as scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
fullTimeEmployees§14500
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Michael  Stubblefield', 'age': 50, 'title': 'President, CEO & Director', 'yearBorn': 1973, 'fiscalYear': 2022, 'totalPay': 1146810, 'exercisedValue': 0, 'unexercisedValue': 6765109}, {'maxAge': 1, 'name': 'Dr. Gerard  Brophy Ph.D.', 'age': 57, 'title': 'Executive VP of Biopharma Production, Executive Officer & Chair of Scientific Advisory Board', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 579468, 'exercisedValue': 1326227, 'unexercisedValue': 67610}, {'maxAge': 1, 'name': 'Mr. Frederic  Vanderhaegen', 'age': 56, 'title': 'Executive Vice President of Europe', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 666119, 'exercisedValue': 0, 'unexercisedValue': 469748}, {'maxAge': 1, 'name': 'Ms. Sheri  Lewis', 'age': 57, 'title': 'Executive Vice President of Global Supply Chain', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 490618, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. R. Brent Jones', 'age': 53, 'title': 'Executive VP & CFO', 'yearBorn': 1970, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Steven W. Eck', 'age': 46, 'title': 'Senior VP, Corporate Controller & Chief Accounting Officer', 'yearBorn': 1977, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Michael  Wondrasch', 'age': 54, 'title': 'Executive VP & Chief Information Officer', 'yearBorn': 1969, 'fiscalYear': 2022, 'totalPay': 808631, 'exercisedValue': 0, 'unexercisedValue': 935093}, {'maxAge': 1, 'name': 'Mr. Tommy J. Thomas CPA', 'title': 'Vice President of Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Claudius O. Sokenu', 'age': 55, 'title': 'Executive VP, Corporate Secretary and Chief Legal & Compliance Officer', 'yearBorn': 1968, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Allison K. Hosak', 'title': 'Senior Vice President of Global Communications & Brand', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§6
boardRisk§2
compensationRisk§4
shareHolderRightsRisk§1
overallRisk§2
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.364
priceToSalesTrailing12Months§2.0937085
currency§USD
dateShortInterest§1702598400
forwardEps§1.08
pegRatio§5.54
exchange§NYQ
quoteType§EQUITY
shortName§Avantor, Inc.
longName§Avantor, Inc.
firstTradeDateEpochUtc§1558099800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§04940212-8f2b-3c14-86b5-6c0c4142577d
messageBoardId§finmb_403055588
gmtOffSetMilliseconds§-18000000
targetHighPrice§30.0
targetLowPrice§19.5
targetMeanPrice§23.72
targetMedianPrice§23.5
recommendationMean§2.2
recommendationKey§buy
numberOfAnalystOpinions§20
quickRatio§0.951
earningsGrowth§-0.354
grossMargins§0.34206
ebitdaMargins§0.19105
trailingPegRatio§None
